This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Procell Therapeutics Inc., Other. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 10 
1 out of 834,513 Years Active: 2013
Title: The Innovations of Daewoong Jo: Pioneering Anti-Cancer Therapeutics
Introduction: Daewoong Jo is a distinguished inventor based in Seoul, South Korea, acclaimed for his significant contributions to the field of cancer therapeutics. With a remarkable portfolio of four patents, Jo's innovations center on creating advanced anti-cancer preparations that leverage the power of recombinant proteins. His pioneering work demonstrates the potentials of biotechnology in combating cancer.
Latest Patents: Jo's latest patents reflect cutting-edge advancements in anti-cancer treatments. One of his notable inventions is a cell-permeable endostatin recombinant protein that incorporates a macromolecule transduction domain (MTD) fused to an angiogenesis inhibitor, endostatin. This patented invention aims to block microvessel formation and impede the migration and proliferation of vascular endothelial cells in tumor tissue, showcasing extraordinary anti-cancer efficacy. Additionally, he has developed a cell-permeable p53 recombinant protein, which enhances the transduction of the tumor suppressor p53 into cell nuclei, subsequently halting excessive cell proliferation and inducing apoptosis in tumor cells. This innovation also advances therapeutic approaches in treating various cancers.
Career Highlights: Throughout his career, Daewoong Jo has made significant strides in the biopharmaceutical sector. He has been associated with Procell Therapeutics Inc., a company dedicated to developing groundbreaking therapies for cancer. His work has been instrumental in the development of innovative solutions aimed at treating complex health challenges.
Collaborations: Jo has collaborated with esteemed colleagues, including Kisuk Park and Jung-Hee Lim, contributing to an enriching exchange of knowledge and expertise in his research endeavors. Their collaboration has fostered advancements in the field of cancer research, further highlighting the impact of teamwork in driving innovation.
Conclusion: Daewoong Jo's inventive spirit and dedication to developing effective anti-cancer therapies solidify his position as a notable figure in the field of biotechnology. His remarkable patents not only illustrate the potential for advanced treatment options but also inspire ongoing research and innovation within the medical community. As Daewoong Jo continues to explore new frontiers in cancer treatment, his contributions will undoubtedly have a lasting impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile